Removal of the prostate gland often eradicates early-stage cancer. But patients whose cancer has spread may need to follow up with what is known as salvage radiation therapy. Researchers at Fox Chase ...

UCLA investigators present the latest radiotherapy research at the American Society for Radiation Oncology annual meeting ...

Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...

Five-treatment stereotactic body radiation therapy (SBRT) provided excellent long-term cancer control with fewer urinary and ...

Case report highlights the importance of a multidisciplinary, evidence-based approach to treating prostate cancer that ...

Brachytherapy and proton therapy are radiation therapies, while HIFU and TULSA are focal therapies with distinct mechanisms. Medicare typically covers HIFU but not TULSA, with potential future ...

Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.

At the 2026 American Society for Radiation Oncology Annual Meeting, held September 26 through 30 in Boston, physicians and ...

Image: Prostate tumour biopsy sample from a patient showing areas with ‘normal’ PTEN protein (brown stained regions) and areas with loss of PTEN protein (blue unstained regions). Credit: Dr Anna ...

Prostate cancer is Australia’s most commonly diagnosed cancer. One in six men will be diagnosed by the time they turn 85. Cancers are abnormal groups of cells that grow uncontrollably and start ...

Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious long-term urinary and bowel health issues, ...